Antibiotic Treatment for Gram-Positive Cocci Bloodstream Infections
For adults with bloodstream infections caused by gram-positive cocci, initiate empiric therapy with vancomycin 15-20 mg/kg IV every 8-12 hours (targeting trough 10-15 μg/mL) while awaiting identification and susceptibility results. Once the specific organism and susceptibilities are known, narrow therapy according to the pathogen-specific regimens below 1, 2.
Initial Empiric Approach
When gram-positive cocci are identified on blood culture Gram stain but before speciation:
- Start vancomycin immediately at 15-20 mg/kg/dose IV every 8-12 hours 1, 2, 3
- This covers methicillin-resistant staphylococci (MRSA/MRSE), streptococci, and most enterococci
- Do NOT routinely add gentamicin to vancomycin empirically—combination therapy increases nephrotoxicity without proven benefit in most cases 1
Organism-Specific Definitive Therapy
Methicillin-Susceptible Staphylococci (MSSA/MSSE)
Switch from vancomycin to cefazolin 2 g IV every 8 hours 1, 4, 2. This is superior to continuing vancomycin and has fewer adverse effects than nafcillin/oxacillin. Alternative options include nafcillin or oxacillin 2 g IV every 4 hours, but cefazolin is preferred based on recent observational data showing better outcomes and lower toxicity 1.
For penicillin allergy:
Methicillin-Resistant Staphylococci (MRSA/MRSE)
Continue vancomycin 15-20 mg/kg IV every 8-12 hours (target trough 10-15 μg/mL) 1, 2, 5.
Critical consideration: If the vancomycin MIC is >1 mg/L, strongly consider switching to an alternative agent even if technically "susceptible," as clinical outcomes worsen 2, 5:
- Daptomycin 6-10 mg/kg IV daily (use 8-10 mg/kg for serious infections to prevent treatment failure) 1, 2
- Linezolid 600 mg IV/PO every 12 hours 1, 2, 5
For prosthetic valve endocarditis, add rifampin 600 mg daily or twice daily 1.
Streptococci (including viridans group)
For penicillin-susceptible strains (MIC ≤0.1 μg/mL):
- Penicillin G 200,000-300,000 units/kg/day IV divided every 4 hours (up to 12-24 million units daily), OR
- Ceftriaxone 2 g IV daily 1, 3
For penicillin-resistant strains (MIC >0.5 μg/mL):
- Ceftriaxone 2 g IV daily, OR
- Vancomycin 15-20 mg/kg IV every 8-12 hours 1
- Consider adding gentamicin 3 mg/kg/day for the first 2 weeks in endocarditis 1
Enterococci
For ampicillin-susceptible strains:
- Ampicillin 2 g IV every 4 hours 1, 6
- Add ceftriaxone 2 g IV every 12 hours OR gentamicin 3 mg/kg/day for synergy in endocarditis 1, 6
For ampicillin-resistant, vancomycin-susceptible strains:
For vancomycin-resistant enterococci (VRE):
- Linezolid 600 mg IV/PO every 12 hours (first-line) 7, 6
- Daptomycin 10-12 mg/kg IV daily (consider combination with ampicillin or ceftaroline for high MICs or persistent bacteremia) 6
Treatment Duration
- Uncomplicated bacteremia: 10-14 days from first negative blood culture 2, 7
- Complicated bacteremia or endocarditis: Minimum 4-6 weeks 1, 2, 6
- Obtain repeat blood cultures 2-4 days after starting appropriate therapy to document clearance
Critical Pitfalls to Avoid
Do not continue vancomycin for MSSA—cefazolin is superior and less toxic 1, 2
Do not use vancomycin monotherapy for enterococcal endocarditis—synergistic combination therapy is required 1, 6
Do not ignore vancomycin MIC values—MIC >1 mg/L predicts poor outcomes even if "susceptible"; switch agents 2, 5
Do not use daptomycin for pneumonia—it is inactivated by pulmonary surfactant 2, 8
Do not add routine aminoglycosides to vancomycin—increased nephrotoxicity without proven benefit except in specific endocarditis cases 1
Monitor linezolid closely if used >2 weeks—risk of bone marrow suppression and neuropathy 6